AssetMark Inc’s Eton Pharmaceutcials ETON Stock Holding History

AssetMark Inc’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$257	Buy	+5	New	+$254	﹤0.01%	3573

Other funds holding ETON

Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Guilbault Capital Metairie, Louisiana $102M AUM 16.14% 1-Year Est. Return

AssetMark Inc's ETON Position: Q3 2026 in Review

AssetMark Inc opened a new position in Eton Pharmaceutcials (ETON) in Q3 2026: 5 shares worth $257. The stake represents ﹤0.01% of the portfolio and ranks #3573 among its holdings.

66 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

AssetMark Inc held 5 shares of Eton Pharmaceutcials worth $257 as of Q3 2026.
Eton Pharmaceutcials was a new AssetMark Inc position in Q3 2026.
Eton Pharmaceutcials made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #3573 holding.
66 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.